The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement from the American Heart Association

Laura J. Davidson, Gilbert H.L. Tang, Edwin C. Ho, Marat Fudim, Tiberio Frisoli, Anton Camaj, Margaret T. Bowers, Sofia Carolina Masri, Pavan Atluri, Joanna Chikwe, Peter J. Mason, Jason C. Kovacic, George D. Dangas

Research output: Contribution to journalReview articlepeer-review


Tricuspid valve disease is an often underrecognized clinical problem that is associated with significant morbidity and mortality. Unfortunately, patients will often present late in their disease course with severe right-sided heart failure, pulmonary hypertension, and life-limiting symptoms that have few durable treatment options. Traditionally, the only treatment for tricuspid valve disease has been medical therapy or surgery; however, there have been increasing interest and success with the use of transcatheter tricuspid valve therapies over the past several years to treat patients with previously limited therapeutic options. The tricuspid valve is complex anatomically, lying adjacent to important anatomic structures such as the right coronary artery and the atrioventricular node, and is the passageway for permanent pacemaker leads into the right ventricle. In addition, the mechanism of tricuspid pathology varies widely between patients, which can be due to primary, secondary, or a combination of causes, meaning that it is not possible for 1 type of device to be suitable for treatment of all cases of tricuspid valve disease. To best visualize the pathology, several modalities of advanced cardiac imaging are often required, including transthoracic echocardiography, transesophageal echocardiography, cardiac computed tomography, and cardiac magnetic resonance imaging, to best visualize the pathology. This detailed imaging provides important information for choosing the ideal transcatheter treatment options for patients with tricuspid valve disease, taking into account the need for the lifetime management of the patient. This review highlights the important background, anatomic considerations, therapeutic options, and future directions with regard to treatment of tricuspid valve disease.

Original languageEnglish
Pages (from-to)E1223-E1238
Issue number22
StatePublished - 28 May 2024


  • AHA Scientific Statements
  • heart failure
  • heart valve prosthesis implantation
  • hypertension, pulmonary
  • tricuspid valve
  • tricuspid valve insufficiency


Dive into the research topics of 'The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement from the American Heart Association'. Together they form a unique fingerprint.

Cite this